Peginterferon alfa-2a Interactions
There are 206 drugs known to interact with peginterferon alfa-2a, along with 10 disease interactions. Of the total drug interactions, 39 are major, 162 are moderate, and 5 are minor.
- View all 206 medications that may interact with peginterferon alfa-2a
- View peginterferon alfa-2a disease interactions (10)
Most frequently checked interactions
View interaction reports for peginterferon alfa-2a and the medicines listed below.
- Acetylsalicylic Acid (aspirin)
- Acidophilus (lactobacillus acidophilus)
- Activated Charcoal (charcoal)
- Adderall (amphetamine / dextroamphetamine)
- Advair Diskus (fluticasone / salmeterol)
- Allegra (fexofenadine)
- Amoxil (amoxicillin)
- Aspirin Low Strength (aspirin)
- Ativan (lorazepam)
- Augmentin (amoxicillin / clavulanate)
- Azstarys (dexmethylphenidate / serdexmethylphenidate)
- B Complex 50 (multivitamin)
- Benadryl (diphenhydramine)
- Celebrex (celecoxib)
- Celexa (citalopram)
- CellCept (mycophenolate mofetil)
- Centrum (multivitamin with minerals)
- Centrum Singles-Beta Carotene (beta-carotene)
- Certa-Vite Senior Plus Lutein (multivitamin with minerals)
- Incivek (telaprevir)
- Klonopin (clonazepam)
- Lamictal (lamotrigine)
- Lexapro (escitalopram)
- Lithium Carbonate ER (lithium)
- Nexium (esomeprazole)
- Paracetamol (acetaminophen)
- RibaPak (ribavirin)
- Topamax (topiramate)
- Vitamin B1 (thiamine)
- Vitamin D3 (cholecalciferol)
Peginterferon alfa-2a disease interactions
There are 10 disease interactions with peginterferon alfa-2a which include:
- renal dysfunction
- autoimmune diseases
- cardiac disease
- autoimmune hepatitis
- depression
- severe hepatic disease
- bone marrow suppression
- endocrine disorders
- ophthalmological disorders
- pulmonary disorders
More about peginterferon alfa-2a
- peginterferon alfa-2a consumer information
- Compare alternatives
- Reviews (17)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antiviral interferons
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.